These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. High efficiency targeting of IFN-α activity: possible applications in fighting tumours and infections. Uzé G; Tavernier J Cytokine Growth Factor Rev; 2015 Apr; 26(2):179-82. PubMed ID: 25466630 [TBL] [Abstract][Full Text] [Related]
6. Interferons as inducers of apoptosis in malignant cells. Kotredes KP; Gamero AM J Interferon Cytokine Res; 2013 Apr; 33(4):162-70. PubMed ID: 23570382 [TBL] [Abstract][Full Text] [Related]
7. Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons. Pfeffer LM; Dinarello CA; Herberman RB; Williams BR; Borden EC; Bordens R; Walter MR; Nagabhushan TL; Trotta PP; Pestka S Cancer Res; 1998 Jun; 58(12):2489-99. PubMed ID: 9635566 [TBL] [Abstract][Full Text] [Related]
8. Usefulness of the results of studies on the antitumor effects of interferon in animals to interferontherapy of patients. Gresser I Recent Results Cancer Res; 1980; 75():226-8. PubMed ID: 6165054 [No Abstract] [Full Text] [Related]
9. A guide to interferon for patients and nurses. Farris JS; Mayer D Oncol Nurs Forum; 1983; 10(4):65-8. PubMed ID: 6195645 [No Abstract] [Full Text] [Related]
10. The antitumor effects of interferon: a personal history. Gresser I Biochimie; 2007; 89(6-7):723-8. PubMed ID: 17451861 [TBL] [Abstract][Full Text] [Related]
11. Interferons and cancer: how the promise is being kept. Borden EC Interferon; 1983; 5():43-83. PubMed ID: 6202643 [No Abstract] [Full Text] [Related]
12. The clinical value of interferons as antitumor agents. Billiau A Eur J Cancer Clin Oncol; 1981 Sep; 17(9):949-67. PubMed ID: 6173223 [No Abstract] [Full Text] [Related]
14. [Interferon: effective but with specific toxicity?]. Dtsch Med Wochenschr; 1981 Jun; 106(26):854-5. PubMed ID: 6165540 [No Abstract] [Full Text] [Related]
15. [Interferon--the prospects and problems of its use in therapeutic and oncological practice]. Poverennyĭ AM Med Radiol (Mosk); 1983 Jun; 28(6):67-71. PubMed ID: 6191171 [No Abstract] [Full Text] [Related]
16. Early events in signalling by interferons. Pellegrini S; Schindler C Trends Biochem Sci; 1993 Sep; 18(9):338-42. PubMed ID: 7694399 [TBL] [Abstract][Full Text] [Related]
17. Type I interferons: ancient peptides with still under-discovered anti-cancer properties. Caraglia M; Dicitore A; Marra M; Castiglioni S; Persani L; Sperlongano P; Tagliaferri P; Abbruzzese A; Vitale G Protein Pept Lett; 2013 Apr; 20(4):412-23. PubMed ID: 23016588 [TBL] [Abstract][Full Text] [Related]
18. [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis]. Herskind C; Fleckenstein K; Lohr J; Li CY; Wenz F; Lohr F Strahlenther Onkol; 2004 Apr; 180(4):187-93. PubMed ID: 15057428 [TBL] [Abstract][Full Text] [Related]